Phase I/II study of liposomal annamycin in patients with refractory or relapsed acute lymphocytic leukemia
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2017
At a glance
- Drugs Annamycin (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions
- Sponsors Synergy Pharmaceuticals Inc
- 07 Jun 2017 Biomarkers information updated
- 23 May 2017 Results (n=8) published in a Moleculin Biotech media release.
- 29 Mar 2006 New trial record.